QuantiFERON value in the diagnosis of tuberculous pleurisy Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015
Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015
Diagnostic value of quantitative measurement of pleural fluid interferon-gamma (IFN–gamma) versus QuantiFERON-TB Gold in tube assays (QFT-IT) in blood, pleural fluid and isolated pleural fluid cells in tuberculous pleural effusion Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Positivity of quantiferon-TB tests in sarcoidosis patients Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
High diagnostic accuracy of immunodiagnosis in sputum smear/PCR-negative pulmonary tuberculosis Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Interferon gamma assays in the diagnosis of TB pleuritis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Aerosol delivery of an immunomodulator (interferon-γ 1b) within mouse lungs Source: International Congress 2015 – Interstitial lung diseases I Year: 2015
Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015
Differential diagnostic efficiency of T cells subsets versus interferon-gamma, tumor necrosis factor alpha and adenosine deaminase in distinguishing tuberculous from malignant pleural effusions Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014
Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015
What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013